Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB26FX7F9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,019
Award facts
- Contract value 100% obligated
- $5,019.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,019.48 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of TYMLOS 80 MCG Dose Pen Injector (1.56ML). This delivery order, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. DMS Pharmaceutical Group Inc. is a critical supplier within the Defense Logistics Agency's pharmaceutical supply chain, with a demonstrated capability to deliver diverse pharmaceutical products and medical consumables to Department of Defense healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition vehicle designed to provide recurring pharmaceutical supplies to military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and effective through December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply branded and generic prescription medications, biologics, over-the-counter drugs, and medical consumables. The contractor's substantial federal contracting activity and consistent performance across multiple therapeutic categories demonstrate its operational readiness to support Department of Defense medical supply requirements globally.
Quick answers
Who was awarded contract SPE2DB26FX7F9?
SPE2DB26FX7F9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FX7F9 worth?
The government has obligated $5,019 on SPE2DB26FX7F9.
Is contract SPE2DB26FX7F9 an order under another contract?
Yes. SPE2DB26FX7F9 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB26FX7F9 competed?
The extent of competition for SPE2DB26FX7F9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award